Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models

Development of personalized cancer vaccines based on neoantigens has become a new direction in cancer immunotherapy. Two forms of cancer vaccines have been widely studied: tumor-associated antigen (including proteins, peptides, or tumor lysates)-pulsed dendritic cell (DC) vaccines and protein- or pe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Immunother
Main Authors: Zhang, Rui, Yuan, Fengjiao, Shu, Yang, Tian, Yaomei, Zhou, Bailing, Yi, Linglu, Zhang, Xueyan, Ding, Zhenyu, Xu, Heng, Yang, Li
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6949210/
https://ncbi.nlm.nih.gov/pubmed/31807878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02448-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados